Search results for "Drug Administration"

showing 10 items of 393 documents

Intermittent intramuscular clodronate therapy: a valuable option for older osteoporotic women

2005

Agingmedicine.medical_specialtyOsteoporosisTreatment outcomeMEDLINE.Injections IntramuscularDrug Administration Schedulelaw.inventionPhysical medicine and rehabilitationPharmacotherapyRandomized controlled triallawBone DensitymedicineHumansFemurVitamin DOsteoporosis PostmenopausalAgedPain MeasurementLumbar Vertebraecalcium clodronic acid vitamin DBone Density Conservation Agentsbusiness.industryGeneral Medicinemedicine.diseaseTreatment OutcomeBack PainPhysical therapyCalciumDrug Therapy CombinationFemaleGeriatrics and GerontologyClodronic Acidbusiness
researchProduct

Anxiolytic-like effects of acute and chronic GABA transporter inhibition in rats.

2002

Acute GABA transporter inhibition can induce anxiolytic-like behaviors. The present analysis addressed whether chronic treatment (23 days via drinking water) with a GABA transporter inhibitor affects rat behavior similar to acute treatment and interferes with additional benzodiazepine-receptor agonistic treatment. Seventy-one rats divided into seven groups were acutely treated with either vehicle, diazepam (2 mg/kg), zolpidem (0.05 mg/kg), tiagabine (19 mg/kg) or chronically with tiagabine with or without acute diazepam or zolpidem. Animals were behaviorally characterized in an elevated plus-maze. None of the treatments induced changes in the activity of the animals. Acute and chronic treat…

AgonistMalemedicine.medical_specialtyElevated plus mazeZolpidemGABA Plasma Membrane Transport ProteinsTime FactorsTiagabinemedicine.drug_classPyridinesNipecotic AcidsOrganic Anion TransportersPharmacologyAnxiolyticDrug Administration Schedulechemistry.chemical_compoundInternal medicinemedicineGABA transporterAnimalsNeurotransmitterMaze LearningTiagabineBiological PsychiatryDiazepambiologyBehavior Animalbusiness.industryMembrane ProteinsMembrane Transport ProteinsDrug SynergismRats Inbred StrainsRatsZolpidemPsychiatry and Mental healthEndocrinologyNeurologychemistryAnti-Anxiety Agentsbiology.proteinNeurology (clinical)businessCarrier ProteinsDiazepammedicine.drugJournal of neural transmission (Vienna, Austria : 1996)
researchProduct

Faldaprevir (BI 201335), BI 207127 and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final results

2013

Background Faldaprevir (BI 201335) and deleobuvir (BI 207127) are direct-acting antiviral agents under development for the treatment of chronic HCV infection. This article describes the final results of the Phase Ib SOUND-C1 study that evaluated the interferon-free oral combination of faldaprevir, deleobuvir and ribavirin in 32 treatment-naive patients infected with HCV genotype 1. Methods Patients were randomized to receive deleobuvir 400 mg ( n=15) or 600 mg ( n=17) three times daily plus faldaprevir 120 mg once daily and weight-based ribavirin for 4 weeks. Interferon-free therapy was followed by response-guided faldaprevir plus pegylated interferon-α2a/ribavirin to week 24 or 48. Results…

Aminoisobutyric AcidsProline[SDV]Life Sciences [q-bio]610 Medicine & healthHepacivirusAntiviral AgentsDrug Administration SchedulePolyethylene GlycolsTherapy naive03 medical and health scienceschemistry.chemical_compound0302 clinical medicineHcv genotype 1LeucineRibavirinMedicine2736 Pharmacology (medical)Pharmacology (medical)Oral therapy030304 developmental biologyPharmacology0303 health sciencesbusiness.industryRibavirinDeleobuvirInterferon-alpha2725 Infectious DiseasesHepatitis C ChronicViral LoadVirologyRecombinant Proteins3. Good healthThiazolesInfectious DiseasesTreatment Outcome10219 Clinic for Gastroenterology and Hepatology3004 PharmacologychemistryAcrylatesFaldaprevirQuinolines030211 gastroenterology & hepatologyBenzimidazolesDrug Therapy CombinationbusinessOligopeptides
researchProduct

Toxicity of the antimalarial artemisinin and its dervatives.

2010

As long as no effective malaria vaccine is available, chemotherapy belongs to the most important weapons fighting malaria. One of the most promising new drug developments is the sesquiterpene artemisinin (ARS) and its derivatives, e.g., artemether, arteether, and sodium artesunate. Large clinical studies and meta-analyses did not show serious side effects, although proper monitoring of adverse effects in developing countries might not be a trivial task. There is a paucity of large-scale clinical trials suitable to detect rare but significant toxicity. Therefore, a final and definitive statement on the safety of artemisinins still cannot be made. In contrast, animal experiments show consider…

ArtemisininsDrug-Related Side Effects and Adverse ReactionsArtesunatePharmacologyToxicologychemistry.chemical_compoundAntimalarialsDogsparasitic diseasesMedicineAnimalsHumansArtemetherArtemisininAdverse effectDeveloping CountriesClinical Trials as Topicbusiness.industryMalaria vaccineDrug Administration Routesmedicine.diseaseArtemisininsMalariaRatschemistryArtesunateToxicityArtemetherRabbitsbusinessSesquiterpenesMalariamedicine.drugCritical reviews in toxicology
researchProduct

Single-dose ebselen does not afford sustained neuroprotection to rats subjected to severe focal cerebral ischemia

2004

Oxygen free radicals have been involved in the pathophysiology of cerebral ischemia, especially after spontaneous or thrombolytic reperfusion. In this study with rats, we have combined a severe focal ischemic insult (2 h) and a prolonged reperfusion time (7 days) to assess the possible sustained neuroprotective effect of ebselen (10 or 100 mg/kg), a small, lipophilic organoselenium compound which mimics glutathione peroxidase. Parietal cortical perfusion was measured by laser-Doppler flowmetry, and focal cerebral ischemia was carried out by the intraluminal thread method. We have measured plasma selenium levels, brain reduced glutathione levels, as a marker of oxidative stress, and infarct …

AzolesMaleTime FactorsCentral nervous systemDrug Evaluation PreclinicalIschemiaAdministration OralIsoindolesPharmacologymedicine.disease_causeNeuroprotectionDrug Administration ScheduleBrain IschemiaSeleniumchemistry.chemical_compoundOrganoselenium CompoundsAnimalsMedicineRats WistarBrain ChemistryPharmacologychemistry.chemical_classificationbusiness.industryEbselenCerebral infarctionGlutathione peroxidaseBody WeightBrainInfarction Middle Cerebral ArteryGlutathionemedicine.diseaseGlutathioneRatsOxidative Stressmedicine.anatomical_structurechemistrySpainAnesthesiaReperfusionReactive Oxygen SpeciesbusinessOxidative stressEuropean Journal of Pharmacology
researchProduct

Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study.

2018

Splenectomy in addition to immunotherapy with rituximab can provide quick and sometimes durable disease control in patients with splenic marginal zone lymphoma (SMZL). However, systemic chemotherapy is ultimately required in many cases. The BRISMA (Bendamustine-rituximab as first-line treatment of splenic marginal zone lymphoma)/IELSG (International Extranodal Lymphoma Study Group)36 trial is an open-label, single arm phase II study designed by the IELSG in cooperation with the Fondazione Italiana Linfomi and the lymphoma Study Association according to Simon's two-stage method. The primary endpoint was complete response rate. Fifty-six patients with SMZL diagnosis confirmed on central revis…

BendamustineAdultMalemedicine.medical_specialtyPhases of clinical researchNeutropeniaGastroenterologyDisease-Free SurvivalDrug Administration ScheduleSettore MED/15 - Malattie Del Sangue03 medical and health sciences0302 clinical medicineInternal medicinefirst-line therapyAntineoplastic Combined Chemotherapy ProtocolsMedicineBendamustine HydrochlorideHumansSplenic marginal zone lymphomabendamustineAgedbusiness.industrySplenic NeoplasmsHematologyLymphoma B-Cell Marginal ZoneMiddle Agedmedicine.diseaseLymphomaimmunochemotherapyRegimenTreatment Outcome030220 oncology & carcinogenesisbendamustine; first-line therapy; immunochemotherapy; rituximab; Splenic Marginal Zone Lymphoma; HematologySplenectomyRituximabFemaleSplenic Marginal Zone LymphomaNeoplasm Recurrence LocalbusinessRituximabFebrile neutropenia030215 immunologymedicine.drugBritish journal of haematology
researchProduct

A novel device for intracolonoscopy cleansing of inadequately prepared colonoscopy patients: a feasibility study.

2019

Abstract Background The importance of high quality preprocedural bowel preparation is widely acknowledged, but suboptimal bowel cleansing still occurs in up to 20 % of all colonoscopy patients. The aim of this study was to evaluate the performance of a novel intraprocedural cleaning device for cleaning poorly prepared colons. Methods This multicenter feasibility study included patients aged 18 – 75 years who were referred for colonoscopy. Intraprocedural cleaning was performed in patients after a limited preprocedural bowel preparation regimen (2 days of dietary restrictions and 2 × 10 mg bisacodyl). The primary outcome was the proportion of adequately prepared patients (Boston Bowel Prepar…

BisacodylMalemedicine.medical_specialtyColonColonoscopyOther Research Radboud Institute for Molecular Life Sciences [Radboudumc 0]Drug Administration SchedulePolyethylene GlycolsTumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14]03 medical and health sciencesAll institutes and research themes of the Radboud University Medical Center0302 clinical medicinePatient satisfactionInterquartile rangemedicineHumansNew deviceBisacodylTherapeutic IrrigationIntraoperative Caremedicine.diagnostic_testbusiness.industryCatharticsGastroenterologyCecal intubationColonoscopyEquipment DesignMiddle AgedSurgeryClinical trialRegimenTreatment OutcomePatient Satisfaction030220 oncology & carcinogenesisInflammatory diseases Radboud Institute for Health Sciences [Radboudumc 5]Feasibility Studies030211 gastroenterology & hepatologyFemalebusinessmedicine.drugEndoscopy
researchProduct

Retrograde transport of sodium selenite and intracellular injection of micro-ruby: a combined method to describe the morphology of zinc-rich neurones.

2003

Abstract Zinc is found in synaptic vesicles in a large number of glutamatergic systems. Its involvement in neurotransmission and neurological disorders has been suggested. There are methods for tracing these circuits, but they do not fill the dendritic tree. In this study, extracellular selenite injections in vivo were combined with intracellular injection of fluorochromes in fixed tissue to reveal the morphology of these zinc-rich neurones. Intraperitoneal and intracerebral injections of sodium selenite alone or intracerebral injections of selenite combined with bisbenzimide were made in the visual cortex of the rat in order to locate the somata of zinc-rich neurones. After 24 h of retrogr…

BisbenzimideMaleSilver StainingBiotinCell CountNeurotransmissionBiologySynaptic vesicleRats Inbred WKYchemistry.chemical_compoundSodium SeleniteBiocytinNeural PathwaysExtracellularAnimalsRats WistarVisual CortexNeuronsLucifer yellowMicroscopy ConfocalRhodaminesGeneral NeuroscienceDrug Administration RoutesLysineDextransSomatosensory CortexIontophoresisIsoquinolinesRatsNeuroanatomyZincnervous systemchemistryBiochemistryAxoplasmic transportBiophysicsInjections JetExtracellular SpaceIntracellularInjections IntraperitonealJournal of neuroscience methods
researchProduct

A CASCADE of effects of bisphenol A

2009

International audience

Bisphenol AHalogenation[SDV]Life Sciences [q-bio]AGENT ENDOCRINOTOXIQUEEndocrine Disruptors010501 environmental sciencesToxicologyPhotochemistry01 natural scienceschemistry.chemical_compoundGovernment regulationPregnancyENDOCRINE DISRUPTIONRISK ASSESSMENTComputingMilieux_MISCELLANEOUSmedia_common0303 health sciencesChemistryEuropeCascadeFemaleCanadamedicine.medical_specialtyFood Contamination03 medical and health sciencesHORMONE RECEPTORSFetusPhenolsInternal medicinemedicineAnimalsHumansmedia_common.cataloged_instance[INFO]Computer Science [cs]European UnionLOW-DOSE EFFECTS DEVELOPMENTBenzhydryl CompoundsEuropean union030304 developmental biology0105 earth and related environmental sciencesDose-Response Relationship DrugUnited States Food and Drug AdministrationInfant NewbornÉVALUATION RISQUEInfant newbornUnited StatesRatsEndocrinologyGovernment RegulationBISPHENOL A
researchProduct

The influence of different generations of computer algorithms on diabetes control

1990

With all control schedules, the management of diabetes is possible using Skyler's algorithm. In general, those control algorithms which do not allow the individual adaptation to changing conditions lead to overinsulinisation. So-called meal-related algorithms do usually minimise the fluctuations in blood sugar. The introduction of self-adapting algorithms, detecting peripheral insulin resistance, may further improve metabolic diabetes control.

Blood GlucoseControl algorithmbusiness.industryControl (management)Blood sugarHealth InformaticsPeripheral insulin resistancemedicine.diseaseDrug Administration ScheduleComputer Science ApplicationsEatingDiabetes controlTherapy Computer-AssistedDiabetes mellitusDiabetes MellitusmedicineHumansInsulinProspective StudiesAdaptation (computer science)businessAlgorithmAlgorithmsSoftwareRetrospective StudiesComputer Methods and Programs in Biomedicine
researchProduct